• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体内证据的天然抗肥胖化合物及衍生物的最新进展:小型综述。

Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.

机构信息

School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan, ROC.

School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan, ROC.

出版信息

Eur J Med Chem. 2022 Jul 5;237:114405. doi: 10.1016/j.ejmech.2022.114405. Epub 2022 Apr 22.

DOI:10.1016/j.ejmech.2022.114405
PMID:35489224
Abstract

Obesity is not only viewed as a chronic aggressive disorder but is also associated with an increased risk for various diseases. Nonetheless, new anti-obesity drugs are an urgent need since few pharmacological choices are available on the market. Natural compounds have served as templates for drug discovery, whereas modified molecules from the leads identified based on in vitro models often reveal noncorresponding bioactivity between in vitro and in vivo studies. Therefore, to provide inspiration for the exploration of innovative anti-obesity agents, recent discoveries of natural anti-obesity compounds with in vivo evidence have been summarized according to their chemical structures, and the comparable efficacy of these compounds is categorized using animal models. In addition, several synthetic derivatives optimized from the phytochemicals are also provided to discuss medicinal chemistry achievements guided by natural sources.

摘要

肥胖不仅被视为一种慢性侵袭性疾病,而且还与各种疾病的风险增加有关。然而,由于市场上可供选择的药物很少,因此急需新型减肥药。天然化合物一直是药物发现的模板,而基于体外模型确定的先导化合物的修饰分子,往往揭示了体外和体内研究之间没有对应的生物活性。因此,为了为探索创新型减肥药提供灵感,根据其化学结构总结了具有体内证据的天然减肥药的最新发现,并使用动物模型对这些化合物的可比功效进行了分类。此外,还提供了从植物化学物质中优化的几种合成衍生物,以讨论受天然来源指导的药物化学成就。

相似文献

1
Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.基于体内证据的天然抗肥胖化合物及衍生物的最新进展:小型综述。
Eur J Med Chem. 2022 Jul 5;237:114405. doi: 10.1016/j.ejmech.2022.114405. Epub 2022 Apr 22.
2
Adipose and non-adipose perspectives of plant derived natural compounds for mitigation of obesity.植物源天然化合物在肥胖缓解中的脂肪和非脂肪观点。
J Ethnopharmacol. 2021 Nov 15;280:114410. doi: 10.1016/j.jep.2021.114410. Epub 2021 Jul 15.
3
Medicinal plants and phytochemicals with anti-obesogenic potentials: A review.具有抗肥胖潜力的药用植物和植物化学物质:综述。
Biomed Pharmacother. 2017 May;89:1442-1452. doi: 10.1016/j.biopha.2017.02.108. Epub 2017 Mar 29.
4
Lead Anti-Obesity Compounds from Nature.天然来源的抗肥胖化合物。
Endocr Metab Immune Disord Drug Targets. 2020;20(10):1637-1653. doi: 10.2174/1871530320666200504092012.
5
Natural Dietary and Herbal Products in Anti-Obesity Treatment.天然饮食和草药产品在抗肥胖治疗中的应用
Molecules. 2016 Oct 11;21(10):1351. doi: 10.3390/molecules21101351.
6
Role of Phytomolecules in the Treatment of Obesity: Targets, Mechanisms and Limitations.植物分子在肥胖治疗中的作用:靶点、机制和局限性。
Curr Top Med Chem. 2021;21(10):863-877. doi: 10.2174/1568026621666210305101804.
7
A review on possible therapeutic targets to contain obesity: The role of phytochemicals.关于控制肥胖的潜在治疗靶点的综述:植物化学物质的作用。
Obes Res Clin Pract. 2016 Jul-Aug;10(4):363-80. doi: 10.1016/j.orcp.2015.12.004. Epub 2015 Dec 28.
8
Phenolic compounds as natural and multifunctional anti-obesity agents: A review.酚类化合物作为天然多功能抗肥胖剂:综述。
Crit Rev Food Sci Nutr. 2019;59(8):1212-1229. doi: 10.1080/10408398.2017.1399859. Epub 2017 Nov 20.
9
Mechanisms of action for the anti-obesogenic activities of phytochemicals.植物化学物抗肥胖作用的作用机制。
Phytochemistry. 2020 Dec;180:112513. doi: 10.1016/j.phytochem.2020.112513. Epub 2020 Sep 30.
10
Adipogenesis and therapeutic potentials of antiobesogenic phytochemicals: Insights from preclinical studies.抗肥胖植物化学物质的脂肪生成作用和治疗潜力:来自临床前研究的见解。
Phytother Res. 2021 Nov;35(11):5936-5960. doi: 10.1002/ptr.7205. Epub 2021 Jul 4.

引用本文的文献

1
Silk Fibroin Nanoparticles as a Drug Delivery System of 3,3'-Diindolylmethane with Potential Antiobesogenic Activity.丝素蛋白纳米颗粒作为具有潜在抗肥胖活性的3,3'-二吲哚甲烷的药物递送系统
ACS Omega. 2024 Nov 20;9(48):47661-47671. doi: 10.1021/acsomega.4c07203. eCollection 2024 Dec 3.
2
lipopeptides inhibit lipase activity and promote 3T3-L1 preadipocyte differentiation.脂肽抑制脂肪酶活性并促进 3T3-L1 前体脂肪细胞分化。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2417915. doi: 10.1080/14756366.2024.2417915. Epub 2024 Oct 21.
3
Bioprospection of rattlesnake venom peptide fractions with anti-adipose and anti-insulin resistance activity .
具有抗脂肪和抗胰岛素抵抗活性的响尾蛇毒肽组分的生物勘探
Toxicon X. 2024 Sep 19;24:100209. doi: 10.1016/j.toxcx.2024.100209. eCollection 2024 Dec.
4
Transdermal microneedle patches as a promising drug delivery system for anti-obesogenic molecules.透皮微针贴片作为一种用于抗肥胖分子的有前景的药物递送系统。
Front Bioeng Biotechnol. 2024 Jun 11;12:1380537. doi: 10.3389/fbioe.2024.1380537. eCollection 2024.
5
A Novel Plant-Based Nutraceutical Combined with Exercise Can Revert Oxidative Status in Plasma and Liver in a Diet-Induced-Obesity Animal Model.一种新型植物源营养保健品与运动相结合可逆转饮食诱导肥胖动物模型中血浆和肝脏的氧化状态。
Antioxidants (Basel). 2024 Feb 23;13(3):274. doi: 10.3390/antiox13030274.
6
A Comprehensive Review of Phytonutrients as a Dietary Therapy for Obesity.植物营养素作为肥胖饮食疗法的综合综述
Foods. 2023 Sep 28;12(19):3610. doi: 10.3390/foods12193610.
7
Pathophysiology of obesity and its associated diseases.肥胖及其相关疾病的病理生理学
Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012. Epub 2023 Jan 13.
8
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2.2 型糖尿病管理的潜在治疗靶点。
Curr Med Chem. 2024;31(21):3167-3181. doi: 10.2174/0929867330666230501172557.
9
Exploring the binding effects and inhibiting mechanism of hyperoside to lipase using multi-spectroscopic approaches, isothermal titration calorimetry, inhibition kinetics and molecular dynamics.采用多光谱方法、等温滴定量热法、抑制动力学和分子动力学研究金丝桃苷对脂肪酶的结合作用及抑制机制。
RSC Adv. 2023 Feb 24;13(10):6507-6517. doi: 10.1039/d2ra06715c. eCollection 2023 Feb 21.
10
Anti-obesity effect of the bacterial product nisin in an NIH Swiss mouse model.在 NIH 瑞士小鼠模型中细菌产物乳链菌肽的抗肥胖作用。
Lipids Health Dis. 2023 Feb 10;22(1):23. doi: 10.1186/s12944-023-01788-1.